TCL Archive In Brief: Survey Expected To Stimulate Surge Of Interest In Finding Etiological Factors In U .S. County-By-County Variations April 19, 1974
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive $14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists October 24, 1996
TCL Archive Appeals Court Lifts Injunction On Federal Funding for Stem Cell Research. September 10, 2010